CD8A and neoplasm: Finally, immunohistochemical staining (Figure 6l,m) was employed to assess the ratio of immune cells infiltrating the tumor in syngeneic tumor allografts, revealing a notable rise in the counts of CD4+ and CD8+ T cells in EVO-treated mice, which indicates that EVO enhances T cell infiltration in tumors.